Glenmark Pharmaceuticals Limited (BOM:532296)
India
· Delayed Price · Currency is INR 2,404.95
+80.10 (3.45%)
At close: Apr 28, 2026
Glenmark Pharmaceuticals Market Cap
Glenmark Pharmaceuticals has a market cap or net worth of 678.33 billion as of April 28, 2026. Its market cap has increased by 60.27% in one year.
Market Cap
678.33B
Enterprise Value
663.66B
Revenue
165.10B
Ranking
n/a
PE Ratio
63.69
Stock Price
2,404.95
Market Cap Chart
Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 678.33B, an increase of 58,920.64%. That is a compound annual growth rate of 29.20%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abbott India | 540.85B |
| GlaxoSmithKline Pharmaceuticals | 414.21B |
| Lupin | 1,062.60B |
| Dr. Reddy's Laboratories | 1,111.14B |
| J. B. Chemicals & Pharmaceuticals | 328.80B |
| Torrent Pharmaceuticals | 1,428.04B |
| AstraZeneca Pharma India | 214.40B |
| Granules India | 172.24B |